Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1955 Jul 23;2(4933):240–242. doi: 10.1136/bmj.2.4933.240

Hepatic Necrosis and Other Visceral Lesions Associated with Phenylbutazone Therapy

Joan M MacCarthy, R T Jackson
PMCID: PMC1980417  PMID: 14389736

Full text

PDF
240

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BRUCK E., FEARNLEY M. E., MEANOCK I., PATLEY H. Phenylbutazone therapy; relation between the toxic and therapeutic effects and the blood level. Lancet. 1954 Jan 30;266(6805):225–228. doi: 10.1016/s0140-6736(54)90874-0. [DOI] [PubMed] [Google Scholar]
  2. CUDKOWICZ L., JACOBS J. H. Phenylbutazone (butazolidine) in the treatment of chronic arthritis. Lancet. 1953 Jan 31;1(6753):223–224. doi: 10.1016/s0140-6736(53)90891-5. [DOI] [PubMed] [Google Scholar]
  3. D'ARCY HART P., REES R. J. W. Enhancing effect of cortisone on tuberculosis in the mouse. Lancet. 1950 Sep 23;2(6630):391–395. doi: 10.1016/s0140-6736(50)91344-4. [DOI] [PubMed] [Google Scholar]
  4. ELLMAN P., CUDKOWICZ L., ELWOOD J. S. Widespread serous membrane involvement by rheumatoid nodules. J Clin Pathol. 1954 Aug;7(3):239–244. doi: 10.1136/jcp.7.3.239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. ENGLEMAN E. P., KRUPP M. A., RINEHART J. F., JONES R. C., GIBSON J. R. Hepatitis following the ingestion of phenylbutazone. J Am Med Assoc. 1954 Sep 11;156(2):98–101. doi: 10.1001/jama.1954.02950020004002. [DOI] [PubMed] [Google Scholar]
  6. FREELAND D., STOREY G., THOMPSON M. Treatment of rheumatoid arthritis with phenylbutazone. Lancet. 1953 Jun 20;1(6773):1227–1229. doi: 10.1016/s0140-6736(53)92259-4. [DOI] [PubMed] [Google Scholar]
  7. JOHNSON B. M., LARKIN I. M. Phenylbutazone and renal function. Br Med J. 1954 Nov 6;2(4896):1088–1089. doi: 10.1136/bmj.2.4896.1088. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. More R. H., McMillan G. C., Duff G. L. The Pathology of Sulfonamide Allergy in Man. Am J Pathol. 1946 Jul;22(4):703–735. [PMC free article] [PubMed] [Google Scholar]
  9. NASSIM J. R. Multiple visceral lesions due o phenylbutazone toxicity. Br Med J. 1954 Oct 30;2(4845):1028–1029. doi: 10.1136/bmj.2.4895.1028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. O'BRIEN D. J., STOREY G. Death from hypersensitivity due to phenylbutazone. Br Med J. 1954 Apr 3;1(4865):792–794. doi: 10.1136/bmj.1.4865.792. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. STEINBERG C. L., BOHROD M. G., ROODENBURG A. I. Agranulocytosis following phenylbutazone (butazolidin) therapy; report of a fatal case. J Am Med Assoc. 1953 May 2;152(1):33–36. doi: 10.1001/jama.1953.63690010009007g. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES